Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation
- Status
- TERMINATED
- Phase
- PHASE2
SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
- Status
- UNKNOWN
- Phase
- NA
The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Addition of Chloroquine to Chemoradiation for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
DC Migration Study for Newly-Diagnosed GBM
- Status
- COMPLETED
- Phase
- PHASE2
Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
- Status
- TERMINATED
- Phase
- PHASE2